Author: Brian Wu, MD candidate, Keck School of Medicine, Los Angeles, USA. DermNet New Zealand Editor in Chief: Hon A/Prof Amanda Oakley, Dermatologist, Hamilton, New Zealand. Copy editor: Maria McGivern. June 2017.
Psoriasis is a common chronic skin condition characterised by symmetrically distributed, well-definedscalyplaques. The most common type of psoriasis is chronic plaque psoriasis, which often starts in early adult life.
What is drug-induced psoriasis?
In some people, psoriasis is drug-induced or drug-aggravated.
In drug-induced psoriasis, discontinuation of the offending drug leads to the clearance of psoriasis. It occurs in patients with no previous history of psoriasis.
In drug-aggravated psoriasis, the disease continues to develop even after the causative drug has been discontinued. It typically occurs in patients with a personal or family history of psoriasis.
These forms of psoriasis differ from psoriasiformdrug eruption, a group of papular drug eruptions characterised histologically by epidermalhyperplasia and hypergranulosis.
Psoriasis induced by lithium
Psoriasis induced by lithium
Psoriasis induced by lithium
Who gets drug-induced psoriasis?
As with psoriasis that is not induced by a drug, drug-induced psoriasis occurs more frequently in patients with a history of:
Palmoplantar pustulosis can also be drug-induced, often by tumour necrosis factor inhibitors. Although closely related, palmoplantarpustulosis is no longer classified as a type of psoriasis. It nearly always occurs in smokers.
How is drug-induced psoriasis diagnosed?
Diagnosis of drug-induced psoriasis can be challenging when patients are on multiple medications. The onset of psoriatic symptoms can be months or years after the drug has been started. Careful patient history is essential in any patient that presents with new-onset psoriasis and must include their current medications. The possibility of other triggers for psoriasis, apart from drugs, should also be taken into consideration.
How is drug-induced psoriasis treated?
The standard of care in the case of drug-induced psoriasis is to discontinue the offending drug. However, this is not always possible; for example, in a patient with severe depression that is well controlled by lithium where other options have been ineffective or contraindicated.
While some cases of drug-induced psoriasis can resolve within weeks of stopping the causative medicine, in other cases, it can take much longer to resolve or not resolve completely.
Buckley L, et al. Abstract #1816. Psoriasis associated with anti-tumor necrosis factor-alpha therapies in children with inflammatory bowel disease, juvenile idiopathic arthritis, and chronic noninfectious osteomyelitis. Presented at: American College of Rheumatology/Association of Rheumatology Professionals Annual Meeting; Nov. 9-13, 2019; Atlanta. Meeting news.